- Home
- ZURA vs NRIM Comparison
ZURA vs NRIM Comparison
Compare ZURA & NRIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ZURA | NRIM |
|---|---|---|
| Founded | 2022 | 1990 |
| Country | United States | United States |
| Employees | 30 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 521.8M | 531.6M |
| IPO Year | N/A | 2002 |
Fundamental Metrics
Financial Performance| Metric | ZURA | NRIM |
|---|---|---|
| Price | $5.60 | $24.81 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $13.00 | N/A |
| AVG Volume (30 Days) | ★ 577.2K | 128.7K |
| Earning Date | 05-07-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 2.58% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.87 |
| Revenue | N/A | ★ $255,581,000.00 |
| Revenue This Year | N/A | $4.98 |
| Revenue Next Year | N/A | $7.40 |
| P/E Ratio | ★ N/A | $8.66 |
| Revenue Growth | N/A | ★ 30.43 |
| 52 Week Low | $0.99 | $19.60 |
| 52 Week High | $7.25 | $99.18 |
Technical Indicators
Market Signals| Indicator | ZURA | NRIM |
|---|---|---|
| Relative Strength Index (RSI) | 41.93 | 64.73 |
| Support Level | $5.35 | $24.60 |
| Resistance Level | $5.75 | $26.25 |
| Average True Range (ATR) | 0.41 | 0.59 |
| MACD | -0.03 | 0.32 |
| Stochastic Oscillator | 29.51 | 92.55 |
Price Performance
Historical ComparisonAbout ZURA Zura Bio Limited
Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.
About NRIM Northrim BanCorp Inc
Northrim BanCorp Inc is a bank holding company. The Company operates in three reportable segments: Community Banking, Home Mortgage Lending, and Specialty Finance. It generates maximum revenue from the Community Banking segment which offers loan and deposit products to business and consumer customers in its market areas and operates nearly 20 branches throughout Alaska.